AKT1 and non-small cell lung carcinoma: Of course, the unexpected effects of Akt1 suppression on cancer metastasis are reported not only in breast cancer but also in prostate, liver, head & neck and non-small cell lung cancer cells (NSCLC) [11, 18, 35, 36].